Search over 3,000 reports

    Invega Sustenna/Xeplion - API Insight, 2017

    Invega Sustenna/Xeplion - API Insight, 2017
    Date: Jan, 2018
    Type: Pharmaceutical Industry Report
    Pages: 30
    Geography: Global
    Delivery Timeline: 48 Hours
    SKU: DIDA0069
    "Invega Sustenna/Xeplion - API Insight, 2018" report by DelveInsight provides product and API manufacturers’ details across US, Europe, China and India for Invega Sustenna/Xeplion . It includes Invega Sustenna/Xeplion overview, mechanism, regulatory milestones, deals & partnerships, clinical trials and other development activities. It further provides Invega Sustenna/Xeplion ’s patents information (US & EU). It also features the historical and forecasted sales of Invega Sustenna/Xeplion till 2020. The report also highlights Invega Sustenna/Xeplion ’s market competition and emerging therapies which are in the same space as Invega Sustenna/Xeplion .

    Methodology
    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    • A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
    • Patent information around Invega Sustenna/Xeplion in United States (US) and Europe (EU) has been highlighted
    • API manufacturers for Invega Sustenna/Xeplion in United States, Europe, China and India
    • The report contains historical and forecasted sales for Invega Sustenna/Xeplion till 2020
    • Enlists the market competition and emerging therapies in the space where Invega Sustenna/Xeplion operates

    Reasons to Buy
    • Establish a comprehensive understanding of the drug, Invega Sustenna/Xeplion
    • Access to Invega Sustenna/Xeplion ’s API manufacturers details to devise API procurement strategy for generic development
    • Plan generic developmental timelines around Invega Sustenna/Xeplion ’s patents for the major markets- US and EU
    • Understand Invega Sustenna/Xeplion ’s current and future growth through its historical and forecasted sales
    • Identify the current in-market competitors for Invega Sustenna/Xeplion
    • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    • Identify the emerging players and their products operating in the same space as Invega Sustenna/Xeplion
    1. Report Introduction
    2. Invega Sustenna/Xeplion Overview
    • Product Description
    • Mechanism of Action
    • Dosage and Administration
    • Pharmacodynamic Properties
    • Pharmacokinetic Properties
    • Safety and Efficacy of Invega Sustenna/Xeplion
    • Clinical Trial Description
    • Adverse Reactions
    • Product Development Activities
    3. Product Details
    • United States
    • Europe
    4. Invega Sustenna/Xeplion Global Sales Assessment
    • Historical Global Sales
    • Forecasted Global Sales
    5. Patent Details
    6. Global API Manufacturers Assessment
    • United States
    • Europe
    • China
    • India
    7. Market Competitors
    8. Emerging Therapies
    9. Appendix
    • Methodology
    • Consulting Services
    • About DelveInsight
    • Contact Us
    • Disclaimer
    Note: Certain sections of the table of contents would vary according to the availability of information
    Table 1: Invega Sustenna/Xeplion Description
    Table 2: Invega Sustenna/Xeplion Product Details, United States
    Table 3: Invega Sustenna/Xeplion Product Details, Europe
    Table 4: Invega Sustenna/Xeplion , Historical Global Sales till 2017 (in million USD)
    Table 5: Invega Sustenna/Xeplion , Forecasted Global Sales from 2018-2020 (in million USD)
    Table 6: Patent Details: Invega Sustenna/Xeplion
    Table 7: API Manufacturers Region wise
    Table 8: API Manufacturers for United States
    Table 9: API Manufacturers for Europe
    Table 10: API Manufacturers for China
    Table 11: API Manufacturers for India
    Table 12: Invega Sustenna/Xeplion Market Competitors
    Table 13: Emerging Therapies
    Figure 1: Invega Sustenna/Xeplion
    Figure 2: Invega Sustenna/Xeplion , Historical Global Sales till 2017 (in million USD)
    Figure 3: Invega Sustenna/Xeplion , Forecasted Global Sales from 2018-2020 (in million USD)
    Figure 4: Patent Details: Invega Sustenna/Xeplion
    Figure 5: API Manufacturers Region wise
    Invega Sustenna/Xeplion

    Invega Sustenna/Xeplion Marketed Drugs Overview

    Invega Sustenna/Xeplion Market Assessment

    Invega Sustenna/Xeplion API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers

    Invega Sustenna/Xeplion US DMF

    Invega Sustenna/Xeplion US Drug Master Files

    Invega Sustenna/Xeplion Active Substance Master File/ EUDMF

    Invega Sustenna/Xeplion Generic players

    Invega Sustenna/Xeplion Patent Expiration

    Invega Sustenna/Xeplion Patent Exclusivity

    Invega Sustenna/Xeplion API Manufacturers

    Invega Sustenna/Xeplion Global Forecasted Sales Figure

    • Single User License
      (20% Off)
      $500.00
    • Site License
      (30% Off)
      $1,000.00
    • Global License
      (40% Off)
      $1,500.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap